Introduction {#Sec1}
============

Dual-source CT is widely used for evaluating lung diseases in children and adolescents. In general, different approaches to decreasing CT radiation exposure have been proposed. One of the most effective methods is the reduction of tube voltage, because the dose increases with the square of the tube voltage. On the other hand, it varies approximately linearly with tube current \[[@CR1]\].

Recently, third-generation dual-source CT scanners have been equipped with additional tin prefiltration that removes low-energy photons of the X-ray beam. These photons contribute little to image quality but increase radiation burden. The so-called spectral shaping has enabled radiation dose reduction in several anatomical regions in adults and children \[[@CR2]--[@CR5]\].

It has been reported that advanced iterative reconstruction enables reduction of radiation dose while preserving image quality in pediatric CT examinations \[[@CR6]\]. Newell et al. \[[@CR7]\] reported a phantom study indicating that third-generation dual-source CT scanners using third-generation iterative reconstruction methods (ADMIRE; Siemens Healthcare, Erlangen, Germany) can generate accurate quantitative CT images with acceptable image noise at very low dose levels. In a study of Rompel et al. \[[@CR8]\], chest CT angiography in newborns and young children performed with a third-generation dual-source CT scanner using a 70-kV protocol together with stronger reconstruction levels of ADMIRE allowed high image quality at low radiation dose level.

We hypothesized that pediatric lung dual-source CT spectral shaping together with a strong reconstruction increment of ADMIRE would enable substantial radiation dose reduction while maintaining an acceptable diagnostic quality. Accordingly, the aim of this study was to identify the percentage value of possible dose reduction compared to a full-dose examination protocol.

Materials and methods {#Sec2}
=====================

We conducted this study in accordance with the guidelines of the Declaration of Helsinki; our local ethics committee approved the study. Written informed consent for dual-source CT of the lung was obtained for all patients. The institutional review board waived supplemental agreement because of the retrospective study design.

Patient characteristics {#Sec3}
-----------------------

A total of 64 patients with dual-source CT examinations of the lung were enrolled in this study. They were retrospectively selected from four examination protocols available in our department. In 16 patients (age 11.2±5.0 years, median 12.4 years, range 2.9--17.7 years) a full-dose (FD) dual-source CT of the lung had been conducted. Forty-eight other patients had been examined using one of three reduced-dose protocols with tin prefiltration (Sn) established in our department (Sn96: *n*=16, 10.3±6.1 years, median 11.6 years, range 1.3--17.7 years; Sn64: *n*=16, 13.1±3.4 years, median 13.1 years, range 5.6--18.0 years; Sn32: *n*=16, 11.4±4.2 years, median 12.8 years, range 4.8--17.6 years). The Sn protocols had been implemented at our institute in order to gradually reduce radiation exposure in clinical routine. Patients of the different groups were matched for age, weight and body mass index. Among all groups there was no significant difference in patient characteristics (Table [1](#Tab1){ref-type="table"}).Table 1Patient characteristics of the different dose groupsDose groupFull-doseSn96Sn64Sn32*P*-value^a^Number of patients16161616Gender9 male,7 female9 male,7 female11 male,5 female12 male,4 femaleAge: mean±SD,median (range), years11.2±5.012.4 (2.9--17.7)10.3±6.111.6 (1.3--17.7)13.1±3.413.1 (5.6--18.0)11.4±4.212.8 (4.8--17.6)ANOVA, *P*=0.435Weight: mean±SD, kg40.9±22.936.1±19.346.9±16.145.6±24.1ANOVA, *P*=0.457Body mass index: mean±SD17.8±3.818.5±4.218.7±3.219.3±5.3ANOVA, *P*=0.791*ANOVA* analysis of variance, *SD* standard deviation, *Sn96/Sn64/Sn32* dose groups with tin prefiltration and different reference tube current--time products (96/64/32 reference mAs, respectively)^a^*P*-value \<0.05 is significant

All patients had been referred for CT to further investigate suspected or known non-cancer lung diseases such as cystic fibrosis, primary ciliary dyskinesia, prolonged course of pneumonia, chronic lung complications of pneumonia, suspected pulmonary hemorrhage, aspiration pneumonitis, pulmonary Langerhans cell histiocytosis, tuberculosis, and atelectasis or pleural effusion of unclear origin.

Dual-source computed tomography techniques {#Sec4}
------------------------------------------

All dual-source CT examinations were performed using the same third-generation scanner (Somatom Definition Force, Siemens Healthcare). CT parameters were as follows: 0.25 s gantry rotation time, detector collimation of 2x96x0.6 mm, slice collimation of 192×0.6 mm using z-flying focal spot technique, spiral pitch factor 3.0, tube voltage modulation switched off. In the full-dose protocol, patients were examined at a 100-kV setting with automatic exposure control (reference tube current time product per rotation 64 mAs; CareDose4D, Siemens Healthcare). In all other protocols 0.6-mm tin prefiltration was applied. Because tin prefiltration is only available at 100-kV and 150-kV tube voltage, with higher diagnostic dose efficiency at 100 kV \[[@CR9]\], the lower kV setting is used in our department. For the three examination protocols with spectral shaping, default values of reference tube current--time product per rotation were 96 mAs/64 mAs/32 mAs. Examinations were performed in supine position with elevated arms from the upper to the lower thoracic aperture. If necessary, a body-weight-adapted dose of iodinated contrast medium was injected intravenously (iomeprol 300 mg/mL, Iomeron, Bracco Imaging, Konstanz, Germany; or Accutron CT-D, Medtron AG, Saarbrücken, Germany).

Postprocessing {#Sec5}
--------------

Primary image data were automatically generated with a slice thickness of 0.6 mm using filtered back-projection (FBP). Additionally, all data sets of examination protocols including tin prefiltration were generated with advanced iterative reconstruction utilizing a medium, an intermediate and a strong increment (ADMIRE strengths 2/3/4). Slice thickness was 0.6 mm, in these protocols, too. In our clinical practice we observed adequate diagnostic quality on full-dose examinations when ADMIRE 2 was used. Consequently, reconstruction of ADMIRE 3 and ADMIRE 4 had not been performed at the time of examinations and thus was not available in the retrospective setting of this study. Iterative reconstruction is characterized by repeated forward and back projection of raw data and image data in combination with statistical modeling. The repeated comparison of projected raw data with the measured data allows removal of geometric imperfections. ADMIRE is built upon these principles, with substantial modifications, allowing a high iteration speed \[[@CR7]\]. It has been shown that ADMIRE has the potential to significantly improve image quality while reducing noise and artifacts in CT scans \[[@CR8], [@CR10], [@CR11]\]. In ADMIRE, images are reconstructed by minimizing the objective function incorporated with an accurate system model, a statistical noise model, and a prior model \[[@CR12]\].

All images were anonymized and transferred to a post-processing 3-D console (SyngoVia VA30A; Siemens Healthcare).

Image analysis {#Sec6}
--------------

Images were analyzed independently by two radiologists (O.R. and M.H., with 25 years and 10 years of experience in pediatric lung CT, respectively), following the European Guidelines on Quality Criteria for CT. The ratings of the two readers were averaged. For all images, a dedicated lung convolution kernel (Bl57) was used, as recommended by the manufacturer. Images were interpreted in axial, coronal and sagittal orientation with 1-mm slice thickness using a multiplanar imaging tool (MM Reading, SyngoVia VA30A; Siemens Healthcare). Maximum- and minimum-intensity projections were allowed to be used at the discretion of the readers. The default window setting was center --600 HU and width 1,700 HU and could be individually adjusted by the readers.

We rated diagnostic confidence as well as detectability of the following anatomical structures on a 4-point Likert scale (1 unacceptable, 2 acceptable under limited conditions, 3 probably acceptable, 4 fully acceptable): medium-size and small pulmonary vessels, tertiary bronchi, lung fissures, lung parenchyma. We also rated suspicious lung lesions with respect to detectability, contrast and contour sharpness using the same 4-point Likert scale.

To assess image quality, we measured noise in the tracheal lumen on 1.0-mm-thick axial images of all datasets (FBP, ADMIRE 2/3/4). Ten randomly selected patients were evaluated ex ante to detect the optimal surface of the circular region of interest (ROI) with respect to the anatomical target regions. Thus, the defined size of ROI was 0.4 cm^2^ for older children and adolescents and 0.2 cm^2^ for smaller children. For each axial image, we performed and averaged three measurements. Image noise was defined as the standard deviation of the attenuation value.

Radiation exposure and effective dose {#Sec7}
-------------------------------------

Radiation exposure was assessed as volumetric CT dose index (CTDI~vol~) and dose--length product (DLP). Estimated effective dose (ED) was calculated as DLP·k, using an individual linear interpolation of the conversion factor reported in literature for chest CT at 100 kV between neonates (k~0~=0.0739 mSv/mGy·cm), 1-year-olds (k~1~=0.048 mSv/mGy·cm), 5-year-olds (k~5~=0.0322 mSv/mGy·cm), 10-year-olds (k~10~=0.0235 mSv/mGy·cm) and 18-year-olds (k~18~=0.0144 mSv/mGy·cm) as a function of days of age \[[@CR8], [@CR13]\].

Statistical analysis {#Sec8}
--------------------

Statistical analysis was performed using SPSS software version 25 (IBM, Armonk, NY) and WINPEPI (Abramson JH, Hebrew University, Jerusalem). Values are given as mean ± standard deviation if normal distribution was assumed by Kolmogorov--Smirnov tests. Nominal variables were also expressed as frequencies. For multiple comparisons one-way analysis of variance (ANOVA) multiple comparison test with Bonferroni and Games--Howell post hoc pairwise comparisons were applied. All tests were performed two-sided, and *P*\<0.05 was considered to be statistically significant. We calculated proportion of inter-rater disagreement and information-based measure of disagreement (IBMD). IBMD measures the level of disagreement between two or more observers. A value of 0 indicates no disagreement, whereas a value of 1 indicates total disagreement \[[@CR14]\].

Results {#Sec9}
=======

Diagnostic confidence {#Sec10}
---------------------

Diagnostic confidence improved in all Sn groups with increasing strength levels of ADMIRE (Table [2](#Tab2){ref-type="table"}). There was no significant difference in diagnostic confidence between the full-dose group reconstructed with ADMIRE 2 and the Sn96 group reconstructed with ADMIRE 4 (FD~ADM2~ vs~.~ Sn96~ADM4~: *P*=0.092). Although differences between the FD~ADM2~ group and the Sn64~ADM4~ and Sn32~ADM4~ groups were significant (FD~ADM2~ vs~.~ Sn64~ADM4~: *P*=0.008; FD~ADM2~ vs~.~ Sn32~ADM4~: *P*\<0.001), diagnostic confidence reached a Likert score \>3 in the Sn64~ADM4~ group. This was not true for the Sn32~ADM4~ group (2.7). For further information see Table [2](#Tab2){ref-type="table"}. The two readers disagreed in 50 of 224 ratings (22%, IBMD 0.10, 95% confidence interval \[CI\] 0.08--0.12).Table 2Diagnostic confidence and detectability of anatomical structures of different dose groupsDose groupFDSn96Sn64Sn32Relevant *P*-values^c^Diagnostic confidenceFBP3.7±0.42.3±0.61.9±0.61.3±0.3^a,b^FD~ADM2~ vs. Sn64~ADM4~:*P*=0.008ADMIRE 23.8±0.52.7±0.42.5±0.41.8±0.4^a,b^FD~ADM2~ vs. Sn32~ADM4~:*P*\<0.001ADMIRE 33.3±0.52.8±0.52.3±0.4^a,b^Sn64~ADM4~ vs. Sn32~ADM4~:*P*=0.058ADMIRE 43.3±0.53.2±0.42.7±0.6^a^Medium-size vesselsFBP3.8±0.53.6±0.73.3±0.42.4±0.5^a,b^FD~ADM2~ vs. Sn64~ADM4~:*P*=1ADMIRE 23.8±0.43.7±0.63.6±0.43.0±0.6^a,b^FD~ADM2~ vs. Sn32~ADM4~:*P*=0.036ADMIRE 33.8±0.53.8±0.43.1±0.7^a,b^Sn64~ADM4~ vs. Sn32~ADM4~:*P*=0.007ADMIRE 43.8±0.43.9±0.23.4±0.7^b^Small vesselsFBP3.5±0.72.3±0.52.0±0.51.3±0.4^a,b^FD~ADM2~ vs. Sn64~ADM4~:*P*=0.468ADMIRE 23.4±0.63.0±0.52.7±0.52.0±0.7^a,b^FD~ADM2~ vs. Sn32~ADM4~:*P*\<0.001ADMIRE 33.1±0.63.1±0.42.1±0.4^a,b^Sn64~ADM4~ vs. Sn32~ADM4~:*P*=0.028ADMIRE 43.2±0.63.1±0.42.5±0.6^a,b^Tertiary bronchiFBP3.8±0.53.1±0.62.8±0.62.2±0.5^a,b^ADMIRE 23.8±0.43.6±0.53.5±0.53.2±0.7FD~ADM2~ vs. Sn64~ADM4~ vs. Sn32~ADM4~:ANOVA *P*=0.132ADMIRE 33.8±0.43.8±0.43.3±0.7^a,b^ADMIRE 43.8±0.43.7±0.43.5±0.5Lung fissuresFBP3.3±0.82.2±0.62.2±0.51.3±0.5^a,b^FD~ADM2~ vs. Sn64~ADM4~:*P*=0.087ADMIRE 23.5±0.72.7±0.72.6±0.81.8±0.8^a,b^FD~ADM2~ vs. Sn32~ADM4~:*P*\<0.001ADMIRE 32.8±0.82.8±0.62.0±0.6^a,b^Sn64~ADM4~ vs. Sn32~ADM4~:*P*=0.008ADMIRE 42.8±0.73.0±0.62.2±0.5^b^Lung parenchymaFBP3.5±0.62.0±0.71.6±0.5^b^1.6±0.5^a^FD~ADM2~ vs. Sn64~ADM4~:*P*=0.001ADMIRE 23.6±0.52.7±0.52.6±0.51.8±0.4^a,b^FD~ADM2~ vs. Sn32~ADM4~:*P*\<0.001ADMIRE 32.6±0.52.5±0.52.1±0.4^a^Sn64~ADM4~ vs. Sn32~ADM4~:*P*=1ADMIRE 42.9±0.52.9±0.42.7±0.5Ratings on a 4-point Likert scale (1 = unacceptable, 2 = acceptable under limited conditions, 3 = probably acceptable, 4 = fully acceptable) of the different dose groups. Values are given as mean ± standard deviation*FBP* filtered back-projection, *FD* full dose, *Sn96/Sn64/Sn32* dose groups with tin prefiltration and different reference tube current time products (96/64/32 reference mAs, respectively)^a^Values significantly lower compared to Sn96^b^Values significantly lower compared to Sn64^c^Relevant *P*-values in respect of the hypothesis

Anatomical structures {#Sec11}
---------------------

In all Sn groups, detectability of anatomical structures improved with increasing strength levels of ADMIRE (Table [2](#Tab2){ref-type="table"}). Compared to FD~ADM2~, values for Sn96~ADM4~, Sn64~ADM4~ and Sn32~ADM4~ were 3.4±0.6 vs. 3.2±0.6, 3.1±0.4 and 2.5±0.6 for small vessels; 3.8±0.4 vs. 3.8±0.4, 3.7±0.4 and 3.5±0.5 for tertiary bronchi; and 3.5±0.7 vs. 2.8±0.7, 3.0±0.6 and 2.2±0.5 for lung fissures. Except for lung parenchyma, no significant differences in detectability of anatomical structures were found between FD~AM2~ and Sn64~ADM4~. On the other hand, differences between Sn64~ADM4~ and Sn32~ADM4~ were statistically significant with the exception of tertiary bronchi and lung parenchyma. More detailed information regarding all evaluated anatomical structures and corresponding values of significance is described in Table [2](#Tab2){ref-type="table"}. An example is given in Fig. [1](#Fig1){ref-type="fig"}. The two readers disagreed in 281 of 1,120 ratings (25%, IBMD 0.10, 95% CI 0.08--0.12).Fig. 1Examples of comparative detectability of anatomical structures in non-affected lung regions on axial CT slices. **FD**~**ADM2**~: full-dose, reconstruction with ADMIRE 2 in a 16-year-old girl with a prolonged course of pneumonia. **Sn96**~**ADM4**~: tin prefiltration, 96 reference mAs, ADMIRE 4 in a 12-year-old boy with atelectasis of the right upper lobe of unclear origin. **Sn64**~**ADM4**~: tin prefiltration, 64 reference mAs, ADMIRE 4 in a 15-year-old girl with suspected fungal pneumonia. **Sn32**~**ADM4**~: tin prefiltration, 32 reference mAs, ADMIRE 4 in a 14-year-old boy with prolonged course of pneumonia. The detectability of small anatomical structures is acceptable in the FD~ADM2~, Sn96~ADM4~ and Sn64~ADM4~ groups but is limited in the Sn32~ADM4~ group. *FD* full-dose group, *Sn96/Sn64/Sn32* groups with tin prefiltration at different reconstruction algorithms (filtered back-projection/ADMIRE 2/3/4)

Suspicious lung lesions {#Sec12}
-----------------------

A total of 231 lung lesions were identified on the CT examinations. Mean diameters of the lesions were 6.1±5.6 mm in the full-dose, 5.0±4.5 mm in the Sn96, 6.2±5.9 mm in the Sn64, and 7.6±6.6 mm in the Sn32 groups (ANOVA: *P*=0.095; Table [3](#Tab3){ref-type="table"}). The lesions comprised subpleural, peribronchovascular or centrilobular nodules, mucoid impaction, tree-in-bud opacities, septal thickening, local ground-glass opacity, circumscribed consolidations, abscess formation, bronchiectasis, pneumatoceles and cavitations.Table 3Characteristics and evaluation of suspicious lung lesions of different dose groupsDose groupFD~ADM2~Sn96~ADM4~Sn64~ADM4~Sn32~ADM4~*P*-value^a^Number of lesions53616453Lesions per patient3.33.84.03.3Size (mm)6.1±5.65.0±4.56.2±5.97.6±6.6FD vs. Sn96 vs. Sn64 vs. Sn32: ANOVA *P*=0.095Detectability3.8±0.33.4±0.63.3±0.73.0±0.7FD vs. Sn96/Sn64/Sn32: *P*\<0.001Sn96 vs. Sn64: *P*=0.985Sn64 vs. Sn32: *P*=0.125Sn96 vs. Sn32: *P*=0.020Contrast3.6±0.52.9±0.72.9±0.62.6±0.7FD vs. Sn96/Sn64/Sn32: *P*\<0.001Sn96 vs. Sn64: *P*=1Sn64 vs. Sn32: *P*=0.177Sn96 vs. Sn32: *P*=0.345Contour sharpness3.5±0.62.9±0.82.8±0.72.3±0.7FD vs. Sn96/Sn64/Sn32: *P*\<0.001Sn96 vs. Sn64: *P*=0.945Sn96/Sn64 vs. Sn32: *P*\<0.001Detectability, contrast and contour sharpness of lesions are rated on a 4-point Likert scale (1 = unacceptable, 2 = acceptable under limited conditions, 3 = probably acceptable, 4 = fully acceptable)*ANOVA* analysis of variance, *FD* full dose, *FD*~*ADM2*~ full dose, reconstruction with ADMIRE 2, *Sn96*~*ADM4*~*/Sn64*~*ADM4*~*/Sn32*~*ADM4*~ tin prefiltration with 96/64/32 reference mAs, respectively, reconstruction with ADMIRE 4^a^ Post-hoc pairwise comparisons are displayed when ANOVA *P*\<0.05

Concerning detectability, contrast and contour sharpness of lesions, differences between the FD~ADM2~ group and all Sn~ADM4~ groups turned out to be significant in terms of statistics (*P*\<0.001; Table [3](#Tab3){ref-type="table"}). Nevertheless, a Likert score value clearly \>3 was reached in the Sn96~ADM4~ and Sn64~ADM4~ groups regarding lesion detectability (3.4 and 3.3; Fig. [2](#Fig2){ref-type="fig"}). Moreover, Sn64~ADM4~ only marginally missed a score value of 3 points concerning contrast (2.9) and contour sharpness (2.8). Compared to the Sn64~ADM4~ group, there were lower score values in the Sn32~ADM4~ group, being significant concerning contour sharpness (2.3, *P*\<0.001; Table [3](#Tab3){ref-type="table"}). An example is given in Fig. [3](#Fig3){ref-type="fig"}. The two readers disagreed in 648 of 2,454 ratings (26%, IBMD 0.12, 95% CI 0.10--0.13).Fig. 2Detectability of suspicious lung lesions (*n*) in the different dose groups rated on a 4-point Likert scale. *FBP* filtered back-projection, *FD* full-dose group, *Sn96/Sn64/Sn32* groups with tin prefiltration at different reconstruction algorithms (FBP/ADMIRE 2/3/4)Fig. 3Examples of comparative detectability of circumscribed consolidations (*arrows*) of cystic fibrosis on axial CT slices. **Sn96**~**ADM4**~: tin prefiltration, 96 reference mAs, ADMIRE 4 in a 14-year-old girl. **Sn64**~**ADM4**~: tin prefiltration, 64 reference mAs, ADMIRE 4 in a 10-year-old boy. **Sn32**~**ADM4**~: tin prefiltration, 32 reference mAs, ADMIRE 4 in a 17-year-old boy. Detectability of circumscribed consolidations is acceptable in the Sn96~ADM4~ and Sn64~ADM4~ groups. In the Sn32~ADM4~ group, interfering noise causes a significant loss of contour sharpness, and detectability is significantly restricted. *Sn96/Sn64/Sn32* groups with tin prefiltration at ADMIRE 4 reconstruction algorithm

Image quality {#Sec13}
-------------

Regarding tin prefiltration, lowering of the reference mAs effected an increase of noise. With increasing strength levels of ADMIRE, noise significantly decreased in all study groups (Fig. [4](#Fig4){ref-type="fig"}). Corresponding values for FBP and ADMIRE 2, 3 and 4 were 78.3±12.1 HU, 61.3±10.5 HU, 50.3±9.4 HU and 40.6±8.0 HU in the Sn96 group; 92.3±18.5 HU, 67.3±12.9 HU, 57.1±11.6 HU and 45.7±9.3 HU in the Sn64 group; and 120.9±15.4 HU, 90.2±12.7 HU, 75.7±11.0 HU and 61.5±9.3 HU in the Sn32 group (*P*\<0.001). An example is given in Fig. [5](#Fig5){ref-type="fig"}. Noise value of the Sn64~ADM4~ group did not statistically differ from that in the FD~ADM2~ group (45.7 vs. 38.8 HU, *P*=0.132; Fig. [4](#Fig4){ref-type="fig"}). On the other hand, noise was significantly higher in the Sn32~ADM4~ group compared to the FD~ADM2~ group (61.5 vs. 38.8 HU; *P*\<0.001) and even to the Sn64~ADM4~ group (61.5 vs. 45.7 HU; *P*\<0.001).Fig. 4Boxplot represents noise measured in the tracheal lumen of patients of the different dose groups. Boxes represent the 25% and 75% quartiles, whiskers the minimum and maximum values. Additionally, significance levels of post hoc pairwise comparisons are displayed for FD~ADM2~ vs. Sn64~ADM4~/Sn32~ADM4~ and Sn64~ADM4~ vs. Sn32~ADM4~. Noise did not statistically differ between FD~ADM2~ group and Sn64~ADM4~ group (*P*=0.132), whereas noise was significantly higher in the Sn32~ADM4~ group compared to the FD~ADM2~/Sn64~ADM4~ groups (*P*\<0.001). *FD* full-dose group, *Sn96/Sn64/Sn32* groups with tin prefiltration at different reconstruction algorithms (filtered back-projection/ADMIRE 2/3/4)Fig. 5Influence of reconstruction algorithms (filtered back-projection \[FBP\], ADMIRE 2/3/4) on image quality and noise in a 10-year-old boy with cystic fibrosis from the Sn64 group (tin prefiltration, 64 reference mAs). Axial CT images depict bronchiectasis (*arrow*), mucoid impaction (*asterisk*) as well as circumscribed consolidations (*arrowhead*). Compared to FBP, noise decreases with increasing strength of ADMIRE

Radiation exposure and effective dose {#Sec14}
-------------------------------------

Compared to the full-dose group, the use of tin prefiltration led to a significantly lower radiation exposure in the Sn96, Sn64 and Sn32 groups. Mean CTDI~vol~ was 2.17±1.2 mGy vs. 0.31±0.14 in the Sn96 group, 0.24±0.10 mGy in Sn64, and 0.13±0.09 mGy in Sn32 (full dose vs. Sn~all~: *P*\<0.001). Corresponding mean DLP was 70.3±44.0 mGy·cm in the FD group vs. 10.5±5.7 mGy·cm in the Sn96 group, 8.2±3.4 mGy·cm in Sn64, and 3.9±2.7 mGy·cm in Sn32 (*P*\<0.001). Consequently, this led to a mean effective dose (ED) of 1.26±0.54 mSv in the FD group vs. 0.21±0.07 mSv in the Sn96 group, 0.14±0.05 mSv in Sn64, and 0.07±0.04 mSv in Sn32 (*P*\<0.001). Among others, dose reduction was statistically significant between full-dose and Sn64 groups, as well as between Sn64 and Sn32 groups (*P*\<0.001). Effective dose was reduced to 16.7%, 11.1% and 5.5% in the Sn96, Sn64 and Sn32 groups, respectively, compared to the full-dose group (Table [4](#Tab4){ref-type="table"}).Table 4Radiation dose exposure and estimated effective dose among different dose groupsDose groupFDSn96Sn64Sn32*P*-value^a^CTDI~Vol~ (mGy)2.17±1.230.31±0.140.24±0.100.13±0.09FD vs. Sn96/Sn64/Sn32: *P*\<0.001Sn64 vs. Sn32: *P*=0.008DLP (mGy·cm)70.3±44.010.5±5.78.2±3.43.9±2.7FD vs. Sn96/Sn64/Sn32: *P*\<0.001 Sn64 vs. Sn32: *P*=0.002ED (mSv)1.26±0.540.21±0.070.14±0.050.07±0.04FD vs. Sn96/Sn64/Sn32: *P*\<0.001 Sn64 vs. Sn32: *P\<*0.001Reduction of ED (percentage value of FD)16.7%11.1%5.5%Values of volumetric CT dose index (CTDI~Vol~), dose--length product (DLP) and effective dose (ED) are given as mean ± standard deviation*FD* full-dose group, *Sn96/Sn64/Sn32* groups with tin prefiltration and different reference tube current time products (96/64/32 reference mAs, respectively)^a^ Significant differences (*P*\<0.05) were found between FD group and all Sn groups, but also between Sn64 and Sn32 groups

Discussion {#Sec15}
==========

In our retrospective study, pediatric lung dual-source CT examinations with spectral shaping led to significantly lower radiation exposure compared to a full-dose protocol. In terms of statistics, dose lowering to about 10% by using the Sn64 protocol caused reduction in diagnostic confidence. Nevertheless, acceptable Likert score values \>3 were achieved for diagnostic confidence as well as detectability of lung lesions when ADMIRE 4 was performed. Simultaneously, there was no significant deterioration of detectability of most anatomical structures, and noise value did not statistically differ from the full-dose group.

There was a significant reduction of radiation exposure between the Sn64 and Sn32 groups. However, further dose reduction to about 5% of the full-dose group by using the Sn32 protocol caused significant loss of contour sharpness of lung lesions compared to the Sn64 group. Even when ADMIRE 4 was performed, visualization of the majority of anatomical structures was significantly reduced. Diagnostic confidence worsened, and noise significantly increased.

In the last few years, several studies proved the potential of lung CT to deliver adequate image quality when protocols with reduced dose were used \[[@CR14]--[@CR16]\]. In a study by Kroft et al. \[[@CR15]\], mean perceived confidence for diagnosis was 98% for lung CT examinations with a mean effective dose of 0.07 mSv. Ebner et al. \[[@CR16]\] investigated chest phantoms with artificial lung nodules between 5 mm and 12 mm at a mean dose level of 0.13 mSv. Sensitivity for nodule detection was 96.2% \[[@CR16]\]. According to Neroladaki et al. \[[@CR17]\], model-based iterative reconstruction allows secure detection of pulmonary nodules in adults at a radiation dose level of 0.16 mSv.

To our knowledge, studies investigating the effect of tin prefiltration on dose reduction are still rare in the pediatric population. Weis et al. \[[@CR18]\] compared a 100-kV pediatric chest CT protocol using spectral shaping (Sn100 kV) with a 70-kV standard protocol. Significant dose reduction up to 0.21 mSv and superior subjective image quality of lung structures was achieved with the Sn100-kV protocol. Consequently, their dose results resemble the mean radiation dose of the Sn96 group in our study. In a phantom study, Martini et al. \[[@CR19]\] analyzed solid and subsolid lung lesions with low-dose protocols using tin prefiltration. Resulting effective doses were comparable to ours (0.14 mSv at 1/8th and 0.05 mSv at 1/20th of standard dose). They reached diagnostic image quality when using ADMIRE Levels 3 or 5. Bodelle et al. \[[@CR5]\] evaluated the effect of spectral shaping on image quality and effects on radiation parameters using a single-source 100-kV pediatric chest protocol. With the use of tin prefiltration, increase of effective tube current up to a factor of 10 provided similar image quality with comparable noise at equivalent dose compared to the standard protocol without spectral filtration. Without spectral shaping, CTDI was 3 times higher compared to our Sn96 group, whereas it was still 2.5 times higher when tin prefiltration was added.

This study has some limitations. Because of its retrospective design, patients' age varied from 1.3 years to 18.0 years, with only few small children being included. Therefore our assertions might not be representative for the last-mentioned. Further research is needed in this area, for example with regard to pulmonary metastases in small children with cancer, which was not part of our study. Moreover, we cannot provide sensitivity of lung lesion detection because no internal reference standard was available for comparison. Instead, we evaluated diagnostic confidence and detectability of both anatomical lung structures and suspicious lung lesions. Sensitivity regarding detection of small pulmonary lesions with reduced-dose protocols is known to be high. Messerli et al. \[[@CR20]\] detected lung nodules in adults with a sensitivity of 91.2% using a low-radiation-dose protocol comparable to our Sn64 protocol. In a phantom study performed by Grodic et al. \[[@CR21]\], sensitivity of pulmonary nodule detection was 94% in a reduced-dose group with tin prefiltration (1/10th of standard dose) and ADMIRE 5. Although results of sensitivity given from these studies cannot be assigned to our collective, they at least tend to support the validity of our findings.

Conclusion {#Sec16}
==========

In pediatric lung dual-source CT with spectral shaping, dose reduction to about 10% of a full-dose protocol still enables acceptable diagnostic quality when image reconstruction is performed with ADMIRE 4.
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